BioPharmSignal logoBioPharmSignal

Biotech News

Charles River Laboratories Announces First-Quarter 2026 Results

Charles River (CRL)Charles River2026-06-25 13:46 ESTEarnings

– Reports First-Quarter Revenue of $995.8 Million, GAAP Loss per Share of $(0.30), and Non-GAAP Earnings per Share of $2.06 – – Reaffirms 2026 Guidance for Organic Revenue and Non-GAAP Earnings per Share – – Repurchased $200 Million of Common Stock in First Quarter of 2026 – – Completed the

Open original release

Related news

CRLCharles River2026-06-25 13:46 EST

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories to Present at William Blair and Jefferies Conferences

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

CRLCharles River2026-06-25 13:46 EST

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

CRLCharles River2026-06-25 13:46 EST

Charles River Enters Manufacturing Collaboration with Gazi University

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories Announces Executive Appointments

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories Provides Update on Planned Divestitures

CRLCharles River2026-06-25 13:46 EST

Charles River Laboratories to Present at TD Cowen and Barclays Conferences

View all latest news

Charles River

Charles River is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CRLCharles River2026-06-26 12:47 EST

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

CRLCharles River2026-06-26 12:47 EST

Charles River Laboratories to Present at William Blair and Jefferies Conferences

CRLCharles River2026-06-26 12:47 EST

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

CRLCharles River2026-06-26 12:47 EST

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

CRLCharles River2026-06-26 12:47 EST

Charles River Laboratories Announces First-Quarter 2026 Results

Stock data

Close
—
Market cap
—
Exchange
NYSE
Sector
Biotechnology
Location
United States